logo
Plus   Neg
Share
Email

Ligand Pharmaceuticals Inc Q3 adjusted earnings Beat Estimates

Ligand Pharmaceuticals Inc (LGND) released earnings for its third quarter that climbed from last year.

The company's profit totaled $67.36 million, or $2.80 per share. This compares with $8.43 million, or $0.36 per share, in last year's third quarter.

Excluding items, Ligand Pharmaceuticals Inc reported adjusted earnings of $31.66 million or $1.32 per share for the period.

Analysts had expected the company to earn $1.03 per share, according to figures compiled by Thomson Reuters. Analysts' estimates typically exclude special items.

The company's revenue for the quarter rose 36.8% to $45.66 million from $33.38 million last year.

Ligand Pharmaceuticals Inc earnings at a glance:

-Earnings (Q3): $31.66 Mln. vs. $15.30 Mln. last year.
-EPS (Q3): $1.32 vs. $0.69 last year.
-Analysts Estimate: $1.03
-Revenue (Q3): $45.66 Mln vs. $33.38 Mln last year.

-Guidance:
Full year revenue guidance: $240 Mln

For comments and feedback contact: editorial@rttnews.com

RELATED NEWS
Follow RTT
>